881 related articles for article (PubMed ID: 18330650)
1. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.
Samphao S; Eremin JM; El-Sheemy M; Eremin O
Ann Surg Oncol; 2008 May; 15(5):1282-96. PubMed ID: 18330650
[TBL] [Abstract][Full Text] [Related]
2. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
3. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
4. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
5. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
6. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
[TBL] [Abstract][Full Text] [Related]
7. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
8. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.
Noguchi M
Eur J Surg Oncol; 2008 Feb; 34(2):129-34. PubMed ID: 17498911
[TBL] [Abstract][Full Text] [Related]
9. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
[TBL] [Abstract][Full Text] [Related]
10. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
[TBL] [Abstract][Full Text] [Related]
11. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
Crane-Okada R; Wascher RA; Elashoff D; Giuliano AE
Ann Surg Oncol; 2008 Jul; 15(7):1996-2005. PubMed ID: 18415650
[TBL] [Abstract][Full Text] [Related]
12. Is axillary dissection needed in node-positive breast cancer?
Greenberg CC; Bafford AC; Golshan M
Expert Rev Anticancer Ther; 2008 Feb; 8(2):195-8. PubMed ID: 18279060
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective.
Catzeddu T; Bertelli G; Del Mastro L; Venturini M
J Surg Oncol; 2004 Mar; 85(3):129-32. PubMed ID: 14991884
[TBL] [Abstract][Full Text] [Related]
14. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
[TBL] [Abstract][Full Text] [Related]
15. Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancer.
Sabel MS; Degnim A; Wilkins EG; Diehl KM; Cimmino VM; Chang AE; Newman LA
Am J Surg; 2004 Jun; 187(6):673-8. PubMed ID: 15191855
[TBL] [Abstract][Full Text] [Related]
16. Impact of omission of axillary lymph node dissection after negative sentinel lymph node biopsy: 70-month follow-up.
Kim HJ; Son BH; Lim WS; Seo JY; Koh BS; Lee JW; Gong GY; Ahn SH
Ann Surg Oncol; 2010 Aug; 17(8):2126-31. PubMed ID: 20162458
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
[TBL] [Abstract][Full Text] [Related]
18. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
Ahlgren J; Holmberg L; Bergh J; Liljegren G
Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
[TBL] [Abstract][Full Text] [Related]
19. Current status of sentinel lymph node biopsy in early breast cancer.
Jatoi I
Int J Fertil Womens Med; 2004; 49(5):215-21. PubMed ID: 15633478
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]